MEDsan Receives Official Approval from EU Members States and Switzerland

Press Release  -  March 17th 2021

MEDsan Receives Official Approval from EU Members States and Switzerland

We’re pleased to confirm that our rapid antigen tests have received official approval from all EU Member States and Switzerland. This is in addition to the official approval we received from the German government in 2020.

These official approvals mean that MEDsan’s rapid antigen test is officially recognised by these countries as a test that has met the standards required to detect the SARS-CoV-2 infection.

MEDsan has been working with governments and authorities around the world throughout the coronavirus pandemic, including the government of Monaco who tested the country’s entire population using our rapid antibody test last year.

For the full details of these approvals, read our approval from EU member states here and our approval from Switzerland here.